BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 21, 2002
View Archived Issues
New compound for toxoplasmosis requires a functional immune system
Read More
Nabi discusses development plans for 2002
Read More
Beyond Genomics and diaDexus enter cancer diagnostic and drug discovery agreement
Read More
Ono-2506 improves outcome in murine models of EAE
Read More
Improved antidiabetic and hypolipidemic activity in a series of dual PPARalpha/PPARgamma agonists
Read More
Commonly used antibiotic shows potential for Rx of multiple sclerosis
Read More
Effects of raloxifene on cardiovascular events analyzed using data from the MORE trial
Read More
AnorMED looks forward to progress in 2002
Read More
EpiDex to be regulated as a medical device in the U.S.
Read More
Preliminary results of transmissible spongiform encephalopathies diagnostic test
Read More
sNDA submitted for Prevacid in pediatric patients
Read More
Positive results from phase I trial of PT-141 in erectile dysfunction
Read More
AGIX-4207 completes phase I in rheumatoid arthritis
Read More
ImmunoGen and Millennium sign exclusive product license
Read More
Chiron completes cash tender offer for Matrix stock
Read More
ML-3000 fails to meet all efficacy endpoints in E.U. trial
Read More
Novel anticancer therapy target validated at Cell Therapeutics
Read More
Casodex 150 mg receives priority review in early-stage prostate cancer
Read More
Sucampo licenses tacrolimus from Fujisawa for ophthalmic use
Read More
DuPont scientists synthesize compounds with CRF-antagonist activity
Read More
Compounds with myocardial electrophysiological activity claimed by AstraZeneca
Read More
Akzo Nobel identifies aminoisoquinoline-containing compounds effective as thrombin inhibitors
Read More
Inhibitors of cyclin-dependent kinases with potential as antitumor agents
Read More
Taisho compounds show utility in CRF-mediated conditions
Read More
Recent patent covers Boehringer Ingelheim compounds useful for the treatment of HCV infection
Read More
Scientists at Nikken Chemicals prepare adenosine derivatives with antihyperlipidemic activity
Read More
FDA Science Forum to be broadcast by Prous Science
Read More
